Camptothecin: current perspectives
Top Cited Papers
- 1 April 2004
- journal article
- review article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 12 (7), 1585-1604
- https://doi.org/10.1016/j.bmc.2003.11.036
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Novel camptothecin derivative BNP1350 in experimental human ovarian cancer: Determination of efficacy and possible mechanisms of resistanceInternational Journal of Cancer, 2002
- Novel C-ring analogues of 20(S)-camptothecin-part-2: Synthesis and
- 7-Silylcamptothecins (silatecans): A new family of camptothecin antitumor agentsBioorganic & Medicinal Chemistry Letters, 1997
- BN 80245: An E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activitiesBioorganic & Medicinal Chemistry Letters, 1997
- Cascade Radical Reactions of Isonitriles: A Second‐Generation Synthesis of (20S)‐Camptothecin, Topotecan, Irinotecan, and GI‐147211CAngewandte Chemie, 1996
- Topoisomerase I inhibitors: topotecan and irenotecanCancer Treatment Reviews, 1994
- New technique for uncoupling the cleavage and religation reactions of Eukaryotic Topoisomerase I.: The mode of action of camptothecin at a specific recognition siteJournal of Molecular Biology, 1991
- The Biogenetically Oriented Total Synthesis of Camptothecin and 7‐ChlorocamptothecinAngewandte Chemie, 1972
- Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecinBiochemical and Biophysical Research Communications, 1971
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966